Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials.
about
Interventions for vitiligoA systematic review of approaches for engaging patients for research on rare diseasesSurvey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligoThe COMET Handbook: version 1.0.Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian PortugueseA review of patient and carer participation and the use of qualitative research in the development of core outcome setsValidation of the Vitiligo Noticeability Scale: a patient-reported outcome measure of vitiligo treatment success.Future horizons in vitiligo research: focusing on the recommendations of the Cochrane systematic review 'Interventions for vitiligo' 2010.Understanding and Evaluating Systematic Reviews and Meta-analysesDeveloping core outcome set for vitiligo clinical trials: international e-Delphi consensus.Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo.Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).Living with vitiligo: development of a new vitiligo burden questionnaire is a step forward for outcomes consensus.Measurement of disease severity in cutaneous autoimmune diseases.Quality of life in vitiligo patients.Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view.Time for a patient-oriented outcome in vitiligo: the vitiligo noticeability scale.Clinical repigmentation patterns in paediatric vitiligo.The validity, reliability and acceptability of the SAVASI; a new self-assessment score in vitiligo.Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial.Vitiligo: Patient stories, self-esteem, and the psychological burden of disease.VitiligoMeasuring outcomes in aphasia research: A review of current practice and an agenda for standardisation
P2860
Q24187979-6F60A164-9702-412B-B0F2-790D119A81F5Q26822274-952F8CF8-4FC2-4D88-A48A-3E3B5214EA2FQ30582008-B3DB5480-1993-4006-9D85-2E8F27DAC2D2Q33877196-75F02499-457C-48F3-8B4E-20018CE569BFQ35892146-78BB4044-D323-455E-8605-0EDB6BEECE14Q36310440-43C98E1C-F5F9-42EA-9AE5-DB4403DA76CFQ37248442-862F81A0-0FF0-4D67-9D0D-A49478181947Q38149877-AC6D7DEE-B9B9-4980-B7BB-83F6665319DCQ38202095-6811B6B1-97DC-4226-84F1-F41F92905F0BQ38341856-35416D0B-C3A8-4DC1-941F-0F76BE230EC3Q38793388-763FE5DD-E18C-4985-A53A-3F8470EC1FCFQ39119588-45704E1F-874B-4179-8EE7-12B1E241923FQ40968887-2BA9E913-47D1-4FF2-8648-8D8C5A00C97AQ41395632-ED138EB7-F674-4395-AA0B-F72E57AB6B4DQ41558860-73ACE991-A08F-4743-BA70-D94EC0DAC37AQ45821223-8EF3CA70-97BB-4B76-926F-9D9578628EC3Q47597459-B9E5739A-D0CD-426E-8F1E-DBF6F0A0083AQ47826853-814DC3C7-8FDB-4B46-BA36-999AD02F6A09Q47839473-19BC1F59-0C01-433A-8153-C957DEA3DF2AQ48041077-5C4041DD-FC17-4FA3-88E8-FE59786FB28BQ55129626-58B4F748-AE36-4994-8DEA-B436EFCFA0DAQ55429802-29F0F393-68CE-4AE3-AA2D-B11E41DB0925Q56996499-713F1883-F306-4204-B721-6E4389745B7FQ58270967-884F5B41-E957-4CC2-AE59-A0C84E9FB51C
P2860
Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Which outcomes should we measu ...... n outcomes in vitiligo trials.
@en
type
label
Which outcomes should we measu ...... n outcomes in vitiligo trials.
@en
prefLabel
Which outcomes should we measu ...... n outcomes in vitiligo trials.
@en
P2093
P2860
P1476
Which outcomes should we measu ...... on outcomes in vitiligo trials
@en
P2093
J C Ravenscroft
J M Batchelor
M E Whitton
V Eleftheriadou
P2860
P304
P356
10.1111/J.1365-2133.2012.11056.X
P407
P50
P577
2012-10-01T00:00:00Z